Private Capital Group, LLC Ngm Biopharmaceuticals Inc Transaction History

Private Capital Group, LLC

  • $133 Million
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022
SELL
$13.81 - $18.6 $1,146 - $1,543
-83 Closed
0 $0
Q4 2021

Jan 24, 2022
SELL
$17.26 - $22.02 $138 - $176
-8 Reduced 8.79%
83 $2,000
Q2 2021

Jul 26, 2021
BUY
$15.06 - $30.03 $1,370 - $2,732
91 New
91 $2,000

Others Institutions Holding NGM

# of Institutions
5
Shares Held
2.6M
Call Options Held
300
Put Options Held
0
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email